T. David Pallin

Cyclic Peptides from Linear Unprotected Peptide Precursors through Thiazolidine Formation

Paolo Botti, T. David Pallin, James P. Tam · Journal of the American Chemical Society · 1996 · 117 citations

Natural Sciences, Biochemistry, Chemistry +15

SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model

Simon Leiris, Alicia Coelho, Jérôme Castandet et al. · ACS Infectious Diseases · 2018 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Selection and early clinical evaluation of the brain‐penetrant 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) inhibitor UE2343 (Xanamem™)

Scott P. Webster, Andrew McBride, Margaret Binnie et al. · British Journal of Pharmacology · 2016 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents

Scott P. Webster, T. David Pallin · Expert Opinion on Therapeutic Patents · 2007 · 39 citations

Life Sciences, Endocrinology, Pharmacology +17

Discovery of <b>ANT3310</b>, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and <i>Acinetobacter baumannii</i>

David T. Davies, Simon Leiris, Magdalena Zalacaín et al. · Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17